GI eosinophilic disorders (EGIDs) are among the fastest growing disease states over the last two decades and an important cause of dysphagia and foregut symptoms. The 2021 James W. Freston Single Topic Conference, Sept. 18-19, will explore the impact of EGIDs on stomach and intestinal maladies and review strategies to use in patient care.
Register by Aug. 6 and save $40.
- Identify the impact of EGIDs on esophagus, stomach and intestinal disorders.
- Acquire effective patient care strategies to mitigate EGID-related GI disorders.
- Outline novel therapeutics from recent phase 3 clinical trials that will support your patient care strategies.
- Discover the genetics, epithelial barrier dysfunction, remodeling, mast cell interactions and food allergies that are the underpinnings of EGIDs.
- Recognize the role of eosinophils and mast cells in other GI disorders such as inflammatory bowel disease, irritable bowel syndrome and non-ulcer dyspepsia.
- Learn the latest therapeutic advances for addressing EGIDs for adults and children with a range of GI disorders.
- Engage with other GI physicians supporting patients with EGIDs. Discover what EGID patient care strategies being implemented by other GI physicians.
Equip yourself with the tools and research to mitigate EGID-related conditions.
